Cabinet approves MoU between India and Canada for cooperation in the field of Science & Technology

2018-01-12 05:21:22

The MoU will provide a mechanism and help to foster scientific cooperation between R&D and academic institutions of India and Canada.By Team ABLEThe Union Cabinet chaired by Prime Minister Shri Narendra Modi has approved a Memorandum of Understanding (MoU) with Canada for cooperation in the field of Science & Technology. The MoU will provide a mechanism and help to foster scientific cooper

Read more

Breed registration is an important step in documenting vast animal genetic resource: Minister Radha Mohan Singh

2018-01-12 05:08:35

Mr Singh said breed registration is an important step in documenting the animal genetic resource and that this process will lead to preparation of an inventory of genetic resources By Team ABLE“There is a need to protect native animal genetic diversity in the global scenario of the World Trade Organization (WTO) and Intellectual Property Rights,” said Union Agriculture and Farmers Welfare Mini

Read more

Abbott, YRGCARE collaborate to track HIV, Hepatitis patterns

2018-01-12 05:05:54

Abbott will provide study protocol and diagnostic equipment and YRGCARE will screen and sequence patient data from infected populations in IndiaBy Team ABLEHealthcare company Abbott and Chennai’s YR Gaitonde Centre for AIDS Research and Education have entered into a partnership to study the country’s viral diversity to improve the accuracy of diagnostic tests for HIV and Hepatitis.Abbott will

Read more

Australia¸ APAC offer international biotech industry a wealth of clinical trial and costs benefits: Novotech

2018-01-12 05:05:04

According to Novotech, the Asia Pacific region has a wealth of clinical trial benefits to offer biotech companies, regardless of their stage of research. By Team ABLEAustralia and the Asia Pacific are fast becoming the destination of choice for the over US$140 billion international biotech industry, with considerable research incentives, supportive regulatory environments and affordable trial cost

Read more

Assam invites investments in Agri biotech sector

2018-01-09 11:49:24

Assam is positioning itself as a major center for phyto pharmaceuticals industry and is wooing investors to the state to develop this sector in a big way.By Narayanan Suresh“Assam is a constituent unit of the Eastern Himalayan Biodiversity Region, one of the two biodiversity ‘hot spots’ in the county and the state is blessed with more than 952 identified species of plants which are used in m

Read more

Serum Institute’s partner NeuClone discloses details of Denosumab’ biosimilar candidate

2018-01-09 07:00:01

NeuClone has partnered with Serum Institute of India for the low-cost manufacture of 10 biosimilars including denosumab. By Team ABLEAustralian biopharmaceutical company NeuClone Pty Ltd has disclosed the fifth biosimilar candidate being developed in its pipeline of monoclonal antibody (mAb) products. The product is a biosimilar candidate for denosumab (branded as Prolia and XGEVA) currently

Read more

Nominations for Biotech Product, Process Development and Commercialization Award 2018 announced

2018-01-09 06:57:59

Up to five awards shall be given every year. Each award will carry a cash amount of Rs 2.00 lakhs along with a citation.By Team ABLE The Department of Biotechnology (DBT) invites nominations from scientists/ innovators/ entrepreneurs/ institutions/companies both in public as well as private sector towards development and commercialization of process/technology/product in the areas of biotechnology

Read more

Ministry of Health and Family Welfare notifies Electronic Health Records verison 2016

2018-01-09 06:54:35

On Jan 5, 2018, the Health Ministry has notified Electronic Health Record (EHR) Standards Version 2016 for India in December 2016 (whilst the earlier version of EHR Standards was notified in September 2013) with an intent to bring standardization and homogeneity, inter-operability in capture, storage, transmission & use of healthcare information across various Health IT systems.According to th

Read more

Momenta-Mylan announce development strategy for a proposed biosimilar to EYLEA

2018-01-07 02:18:10

EYLEA is a vascular endothelial growth factor inhibitor indicated for the treatment of neovascular age-related macular degenerationBy Team ABLEMomenta Pharmaceuticals Inc and Mylan N V have announced the development strategy for M710, a proposed biosimilar to EYLEA (aflibercept) injection. EYLEA is a vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of neovascular (we

Read more

Triesta Unit of HCG to combine with Strand Life Sciences

2018-01-07 02:17:03

The combination of Triesta and Strand is expected to create an integrated platform with end-to-end capabilities in precision medicine, Healthcare Global Enterprises (HCG)By Team ABLEHealthcare Global Enterprises (HCG) has announced execution of definitive agreements for the business combination of its unit Triesta Sciences with bio- informatics firm Strand Life Sciences Pvt Ltd.The combination of

Read more